Clinical trials form the cornerstone of evidence-based medicine and are essential to establishing the safety and efficacy of new drugs. However, only some of the information in clinical trial reports is well-structured and searchable via keywords; much of the information is buried in unstructured text. In the past, uncovering actionable insights from this unstructured text…

In any area of disease research, a deep understanding of recent and future trends surrounding a particular condition is crucial to the drug discovery process. But with the volume of scientific literature increasing all the time, it is difficult to manually sift through all the existing information and correlate data in such a way to…

Pharmaceutical and life sciences companies are faced with a constant stream of new data flowing into often siloed information systems. About 80% of that information exists in unstructured text that is difficult to extract and use, despite its paramount importance in driving clinical and commercial outcomes. As a result, these organizations find themselves increasingly overwhelmed…

One silver lining of the COVID-19 pandemic is that it has accelerated the rate of change for pharma and life sciences fields in general.  The pandemic has forced a rethink of how to manage clinical trials and treat patients in hospitals and their homes. And the breakneck speed of vaccine development in 2020 could potentially…

As governments and health authorities worldwide gear up to deliver potentially billions of COVID-19 vaccine doses, artificial intelligence and data automation techniques could be a powerful tool combating one of the top hindrances to mass vaccination: vaccine hesitancy.   In particular, natural language processing (NLP) could help health authorities transform adverse event reports from COVID-19 vaccines…